Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER_GOV 2OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Carcinoma, Hepatocellular 9Papillomavirus Infections 4Lymphoma, Non-Hodgkin 4Hypertension, Portal 4Febrile Neutropenia 4Carcinoma, Non-Small-Cell Lung 4Polycystic Ovary Syndrome 3Ovarian Cysts 3Multiple Myeloma 3Lung Neoplasms 3Cancer Pain 3Adenomatous Polyposis Coli 3Recurrence 2Rectal Neoplasms 2Prostatic Hyperplasia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Neoplasms 2Lymphoma, B-Cell 2Lymphoma 2Liver Cirrhosis 2Leiomyoma 2Infertility 2Hyperthermia 2Hematologic Neoplasms 2Esophageal Neoplasms 2Vomiting 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Surgical Wound Infection 1

Interventions

acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Finasteride 1Dutasteride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × OTHER_GOV × Prostatic Hyperplasia × Clear all
NCT06001619 2023-08-21

PROMED

Turku University Hospital

Phase 4 Recruiting
100 enrolled
Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms

NCT01876836 2013-06-13

C-LMA

Diskapi Yildirim Beyazit Education and Research Hospital

Phase 4 Unknown
120 enrolled
Genitourinary

Urinary Bladder Neoplasms, Prostatic Hyperplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡